Target intelligence / Profile preview

RNA, U2 small nuclear 50, pseudogene (RNU2-50P)

Target: RNU2-50P
Molecular classification: Other, Pseudogene, Small nuclear RNA pseudogene

Overview

RNA, U2 small nuclear 50, pseudogene (RNU2-50P) is a human pseudogene related to the U2 small nuclear RNA family. U2 snRNAs are involved in pre-mRNA splicing as essential components of the spliceosome; however, RNU2-50P itself is a non-functional pseudogene, meaning it does not encode a functional RNA or protein product. There is no current evidence that RNU2-50P plays a role in disease, functions as a biomarker, or is targeted by any drugs[3]. This distinguishes it from functional variants like RNU2-2, which is involved in neurodevelopmental disorders and gene regulation[1][2], but RNU2-50P is not known to share such features or pathogenic relevance.

Other names: RNU2-50PRNA, U2 Small Nuclear 50, Pseudogene

Beyond the preview

Go deeper on RNA, U2 small nuclear 50, pseudogene (RNU2-50P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 50, pseudogene (RNU2-50P).

Explore the full profile